News

Over the next year, the company will develop its business in the omega-3 consumer healthcare market with initial focus on high concentrate dietary supplement market. The dietary supplement

The compound is used as a treatment for diarrhea, a life-threatening ailment that impacts millions of people across the world. The termination has been done as Salix is

The Technology Strategy Board and Medical Research Council has awarded a Knowledge Transfer Partnership (KTP) grant to Epistem and The University of Manchester to optimise, validate and commercialise

The collaboration covers two late stage compounds from Otsuka- aripiprazole depot formulation and OPC-34712. Aripiprazole depot formulation for schizophrenia is a sterile, lyophilized cake that when reconstituted with

Kadian is used for management of moderate to severe pain that lasts for an extended period of time. Following the approval, the company has started shipping the product.

Sirolimus, an immunosuppressive and anti-proliferative agent, is being assessed in double-masKed Uveitis tReAtment (SAKURA) Phase III study to demonstrate the safety and efficacy of different doses of sirolimus

Baxa is known for developing pharmacy technology to improve the efficiency and safety of oral and IV dose preparation and delivery. Baxter Medical Products business president Robert Davis

Afatinib is an oral, once-daily, tyrosine kinase inhibitor which is being investigated for various tumor types including non-small cell lung (NSCL), breast, head and neck, and colorectal cancers

The new company will continue to provide electronic health records (EHR), practice management and revenue cycle management products. Vitera specializes in products including Intergy, Intergy EHR, Practice Analytics,